News

In trading on Tuesday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (Symbol: FBT) entered into oversold territory, changing hands as low as $198.68 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In the case of First Trust NYSE Arca Biotechnology Index Fund, the RSI reading has hit 29.9 — by comparison, the RSI reading for the S&P 500 is currently 36.7. A bullish investor could look at FBT's 29.9 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.

Looking at a chart of one year performance (below), FBT's low point in its 52 week range is $141.375 per share, with $224.9399 as the 52 week high point — that compares with a last trade of $199.57. First Trust NYSE Arca Biotechnology Index Fund shares are currently trading down about 3.1% on the day.

Click here to find out what 9 other oversold dividend stocks you need to know about »

Also see:

FAII YTD Return
Insulet DMA
Institutional Holders of PSCW

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.